Von hippel-lindau disease and erythrocytosis

Journal of Clinical Oncology

Volumn 30, Issue 13, 2012, Pages

  Capodimonti, Sara ^a   Teofili, Luciana ^a   Martini, Maurizio ^a   Cenci, Tonia ^a   Iachininoto, Maria Grazia ^a   Nuzzolo, Eugenia Rosa ^a   Bianchi, Maria ^a   Murdolo, Marina ^a   Leone, Giuseppe ^a   Larocca, Luigi M ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ALLELE; ARTICLE; CASE REPORT; CHROMOSOME 10; CHROMOSOME 3; DNA DETERMINATION; ERYTHROCYTOSIS; EXON; FLUORESCENCE IN SITU HYBRIDIZATION; GENE; GENE MUTATION; HETEROZYGOSITY; HUMAN; HUMAN CELL; MALE; NUCLEOTIDE SEQUENCE; PHEOCHROMOCYTOMA; PRIORITY JOURNAL; SYMPTOM; VHL GENE; VON HIPPEL LINDAU DISEASE; ADRENAL TUMOR; BIOPSY; BLOOD; GENETIC PREDISPOSITION; GENETICS; MUTATION; PEDIGREE; PHENOTYPE; PHLEBOTOMY; POLYCYTHEMIA; TREATMENT OUTCOME;

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; BIOLOGICAL MARKER; ERYTHROPOIETIN; VHL PROTEIN, HUMAN; VON HIPPEL LINDAU PROTEIN;

ADRENAL GLAND NEOPLASMS; ADULT; ANTICOAGULANTS; ASPIRIN; BIOLOGICAL MARKERS; BIOPSY; DNA MUTATIONAL ANALYSIS; ERYTHROPOIETIN; GENETIC PREDISPOSITION TO DISEASE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MALE; MUTATION; PEDIGREE; PHENOTYPE; PHEOCHROMOCYTOMA; PHLEBOTOMY; POLYCYTHEMIA; TREATMENT OUTCOME; VON HIPPEL-LINDAU DISEASE; VON HIPPEL-LINDAU TUMOR SUPPRESSOR PROTEIN;

EID: 84862984243     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2011.38.6797     Document Type: Article

References (10)

1. Sergeyeva A, Gordeuk VR, Tokarev YN, et al: Congenital polycythemia in Chuvashia. Blood 89:2148-2154, 1997 (Pubitemid 27132132)
2. Ang SO, Chen H, Hirota K, et al: Disruption of oxygen homeostasis underlies congenital Chuvash polycythemia. Nat Genet 32:614-621, 2002 (Pubitemid 35435173)
3. Perrotta S, Nobili B, Ferraro M, et al: Von Hippel-Lindau-dependent polycythemia is endemic on the island of Ischia: Identification of a novel cluster. Blood 107:514-519, 2006 (Pubitemid 43076373)
4. Gordeuk VR, Sergueeva AI, Miasnikova GY, et al: Congenital disorder of oxygen sensing: association of the homozygous Chuvash polycythemia VHL mutation with thrombosis and vascular abnormalities but not tumors. Blood 103:3924-3932, 2004 (Pubitemid 38596314)
5. Miasnikova G, Sergueeva AI, Nouraie M, et al: The heterozygote advantage of the Chuvash polycythemia VHLR200W mutation may be protection against anemia. Haematologica 96:1371-1374, 2011
6. Maher ER, Neumann HP, Richard S: von Hippel-Lindau disease: A clinical and scientific review. Eur J Hum Genet 19:617-623, 2011
7. Nordstrom-O'Brien M, van der Luijt RB, van Rooijen E, et al: Genetic analysis of von Hippel-Lindau disease. Hum Mutat 31:521-537, 2010
8. Yu F, White SB, Zhao Q, et al: HIF-1alpha binding to VHL is regulated by stimulus-sensitive proline hydroxylation. Proc Natl Acad Sci U S A 98:9630-9635, 2001 (Pubitemid 32769354)
9. Krieg M, Marti HH, Plate KH: Coexpression of erythropoietin and vascular endothelial growth factor in nervous system tumors associated with von Hippel- Lindau tumor suppressor gene loss of function. Blood 92:3388-3393, 1998 (Pubitemid 28492349)
10. Da Silva JL, Lacombe C, Bruneval P, et al: Tumor cells are the site of erythropoietin synthesis in human renal cancers associated with polycythemia. Blood 75:577-582, 1990 (Pubitemid 20069194)